DEX — Dextech Medical AB Balance Sheet
0.000.00%
Last trade - 00:00
- SEK94.28m
- SEK72.13m
- 39
- 13
- 45
- 21
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | SAS | SAS | SAS | SAS | SAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 0.011 | 6.09 | 3.46 | 35.5 | 25.2 |
Net Total Receivables | 0.06 | 0.03 | 0.033 | 0.204 | 0.111 |
Prepaid Expenses | |||||
Total Current Assets | 0.382 | 6.37 | 3.75 | 36 | 25.8 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 22.4 | 13.3 | 7.23 | 39.6 | 35 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1.63 | 0.253 | 0.218 | 0.712 | 0.718 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 1.63 | 0.253 | 0.218 | 0.712 | 0.718 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 20.8 | 13.1 | 7.02 | 38.9 | 34.3 |
Total Liabilities & Shareholders' Equity | 22.4 | 13.3 | 7.23 | 39.6 | 35 |
Total Common Shares Outstanding |